Table 13.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1997 to 2006

Recipients with Heart-Lung Transplants

  Transplant Year
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Functioning Graft at Discharge 40 31 34 33 21 22 17 35 29 24
With Immunosuppression Info 38 29 33 33 21 22 17 35 29 24
--- + Steroids 0.0% 0.0% 0.0% 0.0% 4.8% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA 0.0% 3.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA + MMF/MPA + Steroids 15.8% 24.1% 30.3% 36.4% 33.3% 22.7% 17.6% 17.1% 10.3% 8.3%
CyA + OtherAntimet 5.3% 6.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA + OtherAntimet + Steroids 39.5% 24.1% 18.2% 33.3% 38.1% 27.3% 23.5% 14.3% 34.5% 12.5%
CyA + Steroids 2.6% 10.3% 12.1% 3.0% 0.0% 0.0% 0.0% 2.9% 0.0% 4.2%
Tac 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.9% 0.0% 0.0% 0.0%
Tac + MMF/MPA + Steroids 2.6% 10.3% 18.2% 9.1% 19.0% 18.2% 5.9% 34.3% 41.4% 62.5%
Tac + OtherAntimet + Steroids 23.7% 13.8% 6.1% 6.1% 4.8% 18.2% 29.4% 14.3% 6.9% 4.2%
Tac + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.9% 0.0% 0.0%
Tac + Steroids 2.6% 3.4% 3.0% 3.0% 0.0% 4.5% 11.8% 11.4% 3.4% 4.2%
Other Regimen 7.9% 3.4% 12.1% 9.1% 0.0% 9.1% 5.9% 2.9% 3.4% 4.2%


Source: OPTN/SRTR Data as of May 1, 2007.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.